This episode describes how the new NEJM article describing the results of the INBUILD trial make a difference to the way patients with fibrosing ILDs are to be treated going ahead. This has implications for the way fibrosing ILDs are to be read and interpreted by radiologists as well.
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More